16:55 EST Precision BioSciences (DTIL) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DTIL:
- Ten new option listings on November 5th
- Precision BioSciences Reports Q3 2025 Financial Results
- Positive Buy Rating for Precision BioSciences Driven by Promising Clinical Trial Data and Strategic Developments
- Morning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
- Precision BioSciences reports Q3 EPS ($1.84), consensus ($2.21)